CN Patent

CN113939295B — 哒嗪酮及其使用方法

Assigned to Goldfinch Biology Co · Expires 2025-05-16 · 1y expired

What this patent protects

本发明公开了使用式(A)的化合物与第二治疗剂的组合来例如治疗肾脏疾病的治疗性方法。

USPTO Abstract

本发明公开了使用式(A)的化合物与第二治疗剂的组合来例如治疗肾脏疾病的治疗性方法。

Drugs covered by this patent

tepotinib-hydrochloride (TEPOTINIB HYDROCHLORIDE)

Patent Metadata

Patent number: CN113939295B
Jurisdiction: CN
Classification: —
Expires: 2025-05-16
Drug substance claim: No
Drug product claim: No
Assignee: Goldfinch Biology Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.